Teladoc Stock News

TDOC earnings call for the period ending December 31, 2021.

Shares of Teladoc Health Inc. fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw "meaningful growth and penetration across several key areas of our business," including mental health and primary care. "Healthcare has a ''new normal,''" Teladoc said. "We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate." Shares of Teladoc ended the regular trading day up 0.5%.

Teladoc (TDOC) shares are down 4% in the post market despite posting Q4 2021 results that beat on both the top and bottom lines.

Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) with the stream of -0.85% also noticed, India Teladoc Health, Inc. (NYSE:TDOC) encountered a rapid change of -7.79% in the last hour of Fridays trading The post Glistering Stock: Seanergy Maritime Holdings Corp. (NASDAQ:SHIP), Teladoc Health, Inc. (NYSE:TDOC) appeared first on Stocks Equity .

Teladoc Health (NYSE:TDOC) is scheduled to announce Q4 earnings results on Tuesday, February 22nd, after market close.The consensus EPS Estimate is -$0.54 (-100.0% Y/Y) and the…

Teladoc Health (TDOC) is planning to launch its new primary-care product called Primary360 in a bid to face the growing competition in virtual care, Business Insider reported on…

The stock has been under tremendous pressure in the past year, so without stronger results, a turnaround may not happen soon.

The stock is suffering, but business is growing.

Its future isn''t likely to be as rosy as its recent past.

PURCHASE, NY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC ), the global leader in whole-person virtual care, today announced the launch of Chronic Care Complete, a first-of-its-kind chronic condition management solution to help individuals improve their health outcomes while living with multiple chronic conditions. The solution provides members with a unified, comprehensive experience that leverages connected health monitoring devices, access to health coaches, and support from physicians and mental health specialists when needed. Currently, more than one in three adults live with multiple chronic conditions, with those conditions comprising 90 percent of all healthcare spending. Without appropriate care at the right time, chronic conditions can become acute, leading to greater illness and even death. Chronic Care Complete is designed to help people living with chronic conditions improve their health outcomes by providing personalized, high-quality support to address pre-diabetes, diabetes, hypertension, weight management and mental health concerns.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TDOC stock isn''t going to rise for long even if investors get suckered in by earnings and the idea that revenue growth is "strong." The post The Bears Were Right When They Sold Teladoc Months Ago appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Interested in Crypto? Read This First…

WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Connected Health Device Market finds that increasing monitoring home healthcare is expediting market growth. Primarily driven by increasing in the telehealth and remote patient nursing sector, the total global Connected Health Device Market is estimated to reach USD 5.24 Billion by 2028 . The market valued at a revenue of USD 1.92 Billion in the year 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 25.6%. Furthermore, the increasing government support and initiatives and the growing focus on the quality of care and patient safety is also anticipated to augment the growth of the global Connected Health Device Market, states Vantage Market Research, in a report, titled " Connected Health Device Market by Application (Consumer (Patient) Monitoring, Wearable Device, Internally Embedded Device, Stationary Device), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Monday''s top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter and Walmart.

Tesla, Roku and Teladoc Health were the top three holdings in the innovation fund, and are all down at least 19% in 2022

This healthcare industry disruptor''s stock has been beaten down as its COVID-19 tailwind has eased.